Go back to Resources

Clinical trials referral resource. Current clinical trials for the proteosome inhibitor PS-341

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Go back to Resources

Clinical trials referral resource. Current clinical trials administering the antiangiogenesis agent SU5416

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Go back to Resources

Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Go back to Resources

Cancer incidences in Europe related to mortalities, ethnohistoric, genetic, and geographic distances

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Go back to Resources

Assay method, cord blood bank, nucleated cell count, and neonatal factors influence the CD34+ cell count in cord blood: The COBLT Experience

Authors:

Location:

Go back to Resources

Go back to Resources

Acute rejection rate, time to first rejection and rejection reversals comparing the 1987-1989 pediatric renal transplant recipient cohort to the 1997-1999 cohort. A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Authors:

Location:

Go back to Resources

Go back to Resources

Abstract CRYO-ROP risk model prediction of retinopathy (RM-ROP) progression from prethreshold (Th) ROP

Authors:

Location:

Go back to Resources

Go back to Resources

Untitled

Authors:

Location:

Go back to Resources

Go back to Resources

Timing of retinopathy of prematurity (ROP) events: screening implications

Authors:

Location:

Go back to Resources

Go back to Resources

The use of monoclonal therapy in the treatment of intraocular inflammatory disease

Authors:

Location:

Go back to Resources